Picture of Sprott logo

SII Sprott News Story

0.000.00%
us flag iconLast trade - 00:00
FinancialsBalancedMid CapHigh Flyer

Sprott Q3 AUM rises 23%, boosted by ETF launches

Overview

Sprott Q3 AUM rises 23% from prior quarter, driven by market value appreciation and inflows

Adjusted EBITDA for Q3 up 54% yr/yr, benefiting from higher average AUM

Company raises quarterly dividend by 33% to $0.40 per share

Outlook

Sprott highlights confidence in future due to core positioning in precious metals

Company notes positive reception of new ETF offerings

Result Drivers

PRECIOUS METALS APPRECIATION - Rising precious metals prices drove market value appreciation across Sprott's product suite, boosting AUM

RECORD NET SALES - Sprott reported $1.1 bln in net sales for the qtr, with September being the best sales month in company history

ETF SUCCESS - New ETFs launched earlier this year reached key AUM thresholds faster than previous launches, contributing to growth

Key Details

MetricBeat/MissActualConsensus Estimate
Q3 Revenue$49.17 mln
Q3 EPS$0.51
Q3 Net Income$13.15 mln
Q3 Adjusted EBITDA$31.91 mln
Q3 Assets Under Management$49.08 bln
Q3 Dividend$0.40
Analyst Coverage The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell" The average consensus recommendation for the investment management & fund operators peer group is "buy" Wall Street's median 12-month price target for Sprott Inc is C$104.50, about 10.6% below its November 4 closing price of C$115.62 The stock recently traded at 32 times the next 12-month earnings vs. a P/E of 28 three months ago Press Release: ID:nGNX27LZsL For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com. (This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Sprott

See all news